Artificial intelligence for diabetic retinopathy in low-income and middle-income countries: a scoping review

Diabetic retinopathy (DR) is a leading cause of blindness globally. There is growing evidence to support the use of artificial intelligence (AI) in diabetic eye care, particularly for screening populations at risk of sight loss from DR in low-income and middle-income countries (LMICs) where resource...

Descripción completa

Detalles Bibliográficos
Autores principales: Cleland, Charles R, Rwiza, Justus, Evans, Jennifer R, Gordon, Iris, MacLeod, David, Burton, Matthew J, Bascaran, Covadonga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Emerging Technologies, Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401245/
https://www.ncbi.nlm.nih.gov/pubmed/37532460
http://dx.doi.org/10.1136/bmjdrc-2023-003424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401245/
https://www.ncbi.nlm.nih.gov/pubmed/37532460
http://dx.doi.org/10.1136/bmjdrc-2023-003424

Ejemplares similares